Goldman Sachs chief on a flying visit down under
in modern finance will be in Australia
next week. Lloyd Blankfein, chief
executive of Goldman Sachs, is coming
to Sydney.
It will be a strictly fly-in, fly-out occasion to meet investors. But he will be making an appearance at a business conference on Friday in which he will give a talk titled "The global economic outlook and the state of capital markets".
Mr Blankfein has been at the helm of Goldman Sachs during one of the investment bank's most controversial periods.
The bank played a leading role in the purchase and sale of so-called "collateralised debt obligations" - complicated financial derivative products that were linked to the US subprime mortgage market - which contributed to the global financial crisis in 2007.
Mr Blankfein has testified before the US Congress to explain Goldman Sachs' role in the creation and distribution of those CDOs.
At one such hearing, he said the bank had no legal or moral obligation to tell its clients that it was selling them financial product it had created and then betting that those same products would fail, because it was not acting in a fiduciary role.
In April 2010, Goldman Sachs was sued by US regulators for doing so.
In March last year, a former Goldman Sachs employee, Greg Smith, wrote a scathing piece for The New York Times in which he criticised Mr Blankfein for letting the firm's "moral fibre" decline.
"When the history books are written about Goldman Sachs, they may reflect that the current chief executive officer, Lloyd Blankfein, and the president, Gary Cohn, lost hold of the firm's culture on their watch," he wrote.
Critics of the letter said Mr Smith had worked for the bank for 12 years before deciding to go public about the problems inside it.
Frequently Asked Questions about this Article…
Lloyd Blankfein is the chief executive of Goldman Sachs. The article says he was due to visit Sydney on a fly-in, fly-out trip to meet investors and speak at a business conference, making his visit notable because he leads one of the world’s most influential and controversial investment banks.
According to the article, he was scheduled to give a talk titled “The global economic outlook and the state of capital markets,” a topic that speaks directly to market conditions and investor sentiment — subjects many everyday investors follow closely.
The article highlights Blankfein’s role at Goldman Sachs during the period when the bank was heavily involved in buying and selling collateralised debt obligations (CDOs) linked to the US subprime mortgage market. That activity contributed to the 2007 global financial crisis and led to congressional testimony and regulatory scrutiny, which made him a polarising figure.
The article describes CDOs as complicated financial derivative products linked to the US subprime mortgage market. It says Goldman Sachs played a leading role in the purchase and sale of those CDOs, and that activity was part of what contributed to the global financial crisis in 2007.
Yes. The article states that in April 2010 Goldman Sachs was sued by US regulators over its conduct related to those CDOs.
The article reports that in congressional testimony Blankfein said the bank had no legal or moral obligation to tell clients it was selling financial products it had created and then betting those products would fail, because Goldman was not acting in a fiduciary role in those transactions.
The article notes that Greg Smith wrote a scathing piece for The New York Times accusing Blankfein and others of letting the firm’s “moral fibre” decline. Critics of the letter pointed out Smith had worked at the bank for 12 years before going public. For investors, such criticisms highlight concerns about firm culture, client treatment and reputational risk.
Based on the article, Blankfein’s visit and past controversies at Goldman Sachs are a reminder that regulatory scrutiny, corporate culture and reputational issues can affect major financial firms. Everyday investors may want to monitor how such firms respond to scrutiny, the transparency of their disclosures, and any regulatory developments that could influence markets — while keeping personal investment decisions aligned with their own goals and risk tolerance.
Call 1300 880 160
Start a chat
Schedule a call
